NeuroOne Medical Technologies Corp (NMTC) Price Prediction & ForecastNMTCNeuroOne Medical Technologies Corp

Alphio's NMTC stock price prediction model matches the current NeuroOne Medical Technologies Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.84 (-0.72%). The 1-week path is $0.91 (+7.40%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Neuroone Medical Technologies Corp is currently not a strong buy due to its recent performance and financial challenges, despite some positive indicators. The current price is $0.8501, with an RSI of 40.595 indicating it is nearing oversold territory. However, the company has seen a significant year-to-date change of -83.38% and a 20-day change of -24.10%, which raises concerns about its short-term viability. While the gross margin has improved to 59.94%, the company continues to report losses, with a net income of -$2,006,331 in Q3 2026. The main risk is its deteriorating cash position, which has dropped from $6.6 million to $2.8 million, potentially limiting its operational capacity.

NeuroOne Medical Technologies Corp (NMTC) last closed at $0.8501, losing -1.27%. These facts feed the 1-day and 1-week NMTC price prediction above.